Owners, management and financials
CVR: 37368598
DKK 15,902,080
Gross profit
Net result: DKK 3,684,788
Bill Holding ApS (50-66,65%), by.david ApS (33,33-49,99%)
CVR · view owners
Thomas Bill Madsen, Ray David Sossna
CVR · view management
Active
Founded 14 January 2016
CVR · view overview
6 employees
CVR · 2018
Director registered: Ray David Sossna
CVR · 07/01/2019
View the full event history
Nordic Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2016. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Bill Madsen and Ray David Sossna. The company is owned by Bill Holding ApS and by.david ApS. The company has 6 employees (2018). In 2025, the company reported a gross profit of DKK 15,902,080 and a net result of DKK 3,684,788 compared with DKK 2,966,376 the year before. Equity in the 2025 report amounted to DKK 4,487,385.
Source: annual report 2025, Danish Business Authority
Nordic Pharma Consulting ApS demonstrates a strong financial trajectory, with consistent growth in gross profit and profit over the past five years. In 2025, gross profit reached 15,902,080 DKK, up from 11,213,012 DKK in 2023, while profit increased from 1,588,832 DKK to 3,684,788 DKK in the same period. The company's equity has also shown a positive trend, rising from 2,391,429 DKK in 2023 to 4,487,385 DKK in 2025, indicating a solid financial foundation. However, the lack of disclosed revenue figures raises concerns about transparency and overall market position within the business consulting industry. Overall, the company appears to be well-positioned for continued growth, supported by improving margins and equity.
AI-generated summary · Generated 15/08/2026
Selskabets formål er at drive konsulentvirksomhed indenfor produktion og logistik.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 15.9 mio. | 3.7 mio. | 7.9 mio. | 4.5 mio. | 10 | |
| 202401/01/2024 – 31/12/2024 | 14.1 mio. | 3 mio. | 8.1 mio. | 3.8 mio. | 8 | |
| 202301/01/2023 – 31/12/2023 | 11.2 mio. | 1.6 mio. | 5.2 mio. | 2.4 mio. | 7 | |
| 202201/01/2022 – 31/12/2022 | 11.6 mio. | 3.6 mio. | 10.2 mio. | 4.4 mio. | 6 | |
| 202101/01/2021 – 31/12/2021 | 8.8 mio. | 1.8 mio. | 5.1 mio. | 2.6 mio. | 6 | |
| 202001/01/2020 – 31/12/2020 | 8.9 mio. | 1.5 mio. | 4.6 mio. | 2.3 mio. | 5 | |
| 201901/01/2019 – 31/12/2019 | 8.6 mio. | 752 t. | 2.2 mio. | 803 t. | - | |
| 201801/01/2018 – 31/12/2018 | 7 mio. | 493 t. | 2.3 mio. | 748 t. | - | |
| 201701/01/2017 – 31/12/2017 | 6 mio. | 785 t. | 2.4 mio. | 855 t. | - | |
| 201614/01/2016 – 31/12/2016 | 1.7 mio. | 620 t. | 1.3 mio. | 670 t. | - |
Compared to 11.550 companies in Virksomhedsrådgivning og anden ledelsesrådgivning
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of Nordic Pharma Consulting ApS is 37368598.
Nordic Pharma Consulting ApS is owned by Bill Holding ApS and by.david ApS.
The management of Nordic Pharma Consulting ApS consists of Thomas Bill Madsen and Ray David Sossna.
In 2025, Nordic Pharma Consulting ApS reported a gross profit of DKK 15,902,080.
Nordic Pharma Consulting ApS had 6 employees in 2018 according to the Danish CVR register.
Nordic Pharma Consulting ApS was founded on 14 January 2016.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 23645858, new email: [email protected] (August 7, 2026).
Nordic Pharma Consulting ApS has published its annual report for 2025. Gross profit came to DKK 15,902,080, and the net result was DKK 3,684,788.
Nordic Pharma Consulting ApS has published its annual report for 2024. Gross profit came to DKK 14,101,873, and the net result was DKK 2,966,376.
Nordic Pharma Consulting ApS has published its annual report for 2023. Gross profit came to DKK 11,213,012, and the net result was DKK 1,588,832.
Nordic Pharma Consulting ApS has published its annual report for 2022. Gross profit came to DKK 11,622,261, and the net result was DKK 3,594,582.
As of March 15, 2023, REDMARK, GODKENDT REVISIONSPARTNERSELSKAB has been appointed auditor of Nordic Pharma Consulting ApS.
As of March 15, 2023, 18. juni 2024 P/S has stepped down as auditor of Nordic Pharma Consulting ApS.
Nordic Pharma Consulting ApS has published its annual report for 2021. Gross profit came to DKK 8,840,664, and the net result was DKK 1,820,384.
As of February 28, 2022, 18. juni 2024 P/S has been appointed auditor of Nordic Pharma Consulting ApS.
Nordic Pharma Consulting ApS has published its annual report for 2020. Gross profit came to DKK 8,895,814, and the net result was DKK 1,519,615.
Nordic Pharma Consulting ApS has published its annual report for 2019. Gross profit came to DKK 8,594,718, and the net result was DKK 751,731.
Nordic Pharma Consulting ApS has published its annual report for 2018. Gross profit came to DKK 6,963,201, and the net result was DKK 492,599.
As of January 7, 2019, Ray David Sossna is registered as director of Nordic Pharma Consulting ApS.
As of January 7, 2019, by.david ApS is registered as an owner of Nordic Pharma Consulting ApS with an ownership share of 33%.
Nordic Pharma Consulting ApS has published its annual report for 2017. Gross profit came to DKK 5,989,446, and the net result was DKK 785,477.
As of January 14, 2016, Thomas Bill Madsen is registered as adm. dir. of Nordic Pharma Consulting ApS.
As of January 14, 2016, Bill Holding ApS is registered as an owner of Nordic Pharma Consulting ApS with an ownership share of 50%.
Nordic Pharma Consulting ApS was founded on January 14, 2016.
Companies in the same industry and area
CVR 26808332
CVR 18939975
CVR 29654891
CVR 27422500
CVR 40893377
